IDT Biologika News

Read about the latest news and developments at IDT Biologika, including the company’s growth, innovations and community involvement.
You can also access our entire archive of press releases and follow our activity on social media.

30 new laboratories for the vaccines of the future more info

Official transfer of ownership more info

Rockville expands the IDT vaccine development and production offer more info

IDT Biologika Awarded 10-Year NIH Contract

Friday, 19. October 2018

IDT Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases more info

CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine

Monday, 20. August 2018

CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine more info

25th anniversary of the privatization of IDT Biologika

Friday, 29. June 2018

Prime Minister hails exemplary success story more info

IDT Biologika acquires Dr. Felgenträger, located in the BioPharmaPark Dessau

Tuesday, 24. April 2018

The pharmaceuticals company intends to use this takeover to continue expanding its herd-specific vaccine business more info

CMO Leadership Award 2018

Monday, 26. March 2018

IDT Biologika receives three Life Science Leader’s more info

Twitter
@IDT Biologika

Thursday, 18. October 2018

RT @PBOAssoc: Member news: @idtbiologika Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseas… more info

Thursday, 11. October 2018

RT @IMG_ST: German region for #pharmaceuticals #SaxonyAnhalt: 20 companies at the @CPhIWW 2018 in Madrid. Like #cytostatics producer Oncot… more info

Thursday, 11. October 2018

RT @vaccinenation: We are so pleased to have the sponsorship of @idtbiologika for the WVC EU this year. Thank you very much, we can't wait… more info

External Corporate Communications

If you are a journalist and have any questions, please don't hesitate to contact us.

Kontaktformular

Christian Herschel

External Corporate Communications